Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Drug Coding Drops Six-Month Marketing Requirement

Executive Summary

Pharmaceutical manufacturers will no longer need to submit six months of marketing data for a drug when seeking a Medicare reimbursement code

You may also be interested in...



CMS Innovation Council To Examine Pharmacogenomic Product Coverage

The Centers for Medicare & Medicaid Services' Council for Technology & Innovation will consider coverage of pharmacogenomic products

HCPCS Code Six-Month Marketing Prerequisite Is Unnecessary, PhRMA Says

The Centers for Medicare & Medicaid Services should eliminate the six-month marketing prerequisite for applying to receive an HCPCS code for Medicare reimbursement, PhRMA said in comments to HHS' Committee on Regulatory Reform

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

PS044805

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel